Avadel Pharmaceuticals(us:AVDL)
10.11
-1.94%
Updated on 2024-12-23
Open:10.30
Close:10.11
High:10.45
Low:9.97
Pre Close:10.31
Volume:398880.00
Amount:4.04M
Turnover:0.41%
Shares:96.27M
MarketCap:973.30M
About Avadel Pharmaceuticals Company
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Company Name: Avadel Pharmaceuticals
Company Address: 10 Earlsfort Terrace
Employees: 154
Fiscar Year: 12-31
IPO Date: 1996-06-06
Website: http://www.avadel.com
CIK: 1012477
View all SEC Filings
About
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.
Address:10 Earlsfort Terrace
Website:http://www.avadel.com
Market Movers